The coronavirus disease 2019 (COVID-19) is our latest pandemic, preceded by the H1N1
swine flu in 2009, which lasted approximately 19 months. One of the special characteristics …

Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations,
leading in some cases to a critical condition with poor long-term outcomes and residual …

ABSTRACT COVID-19 pneumonia has been associated with high rates of thrombo-embolic
complications, mostly venous thromboembolism (VTE), which is thought to be a combination …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

Abstract Coronavirus disease (COVID-19) is caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and is responsible for the ongoing 2019–2020 …

Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months,
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …

Abstract Purpose of Review Novel coronavirus disease 2019 (COVID-19) has been
associated with an increased risk of arterial and venous thromboembolic (VTE) diseases …

BACKGROUND Emerging evidence shows that severe COVID-19 can be complicated by a
significant coagulopathy, that likely manifests in the form of both microthrombosis and …